.png)
Next-Gen
Tumor Models
For Research & Drug Development.
The Challenge
Close to 95% of new cancer drugs fail during clinical trials. Drug development has also become slower and more expensive in a phenomenon known as Erooms Law. One of the root causes of these problems is that the tools researchers use for efficacy testing, such as 2D cell cultures and murine models, do not accurately depict human biology.
OUR SOLUTION
TUMOROIDS-ON-A-CHIP
3-in-1 Plate
ADVANTAGES
-
Tumor models + extracellular matrix + drug testing. All-in-one platform.
-
Uniform tumor models.
-
In situ IHC analysis.
-
Effortless on-plate immunostaining and imaging.
-
Only one tumoroid per well, eliminating the possibility of inter-model crosstalk.
EZ-Seed Plate
ADVANTAGES
-
One step cell seeding.
-
Monosize spheroids for experimental consistency.
-
Effortless immunostaining and imaging.
-
Platform is directly embeddable in paraffin for IHC and H&E analysis.
Our Partners
Research Institutes and Universities
Pre-clinical CROs
Pharma and Drug Developers
2
1
10
What Are Tumoroids?
Tumoroids are three dimensional clusters of tumor cells grown in vitro. They are also known as tumor spheroids or organoids. These structures mimic important aspects of the tumor microenvironment such as cell-cell and cell-matrix interactions, making them important models for both basic cancer research and drug testing. They are also amenable to a wide variety of assays and cancer/cell types.
Rewriting Erooms Law.
